Skip to content
GE HealthCare logo

GEHC

GE HealthCare

NASDAQHealth CareMedical DevicesSnapshot 2026-05-08

$63.47+3.47%
Close 2026-05-08 · 1-day change
The bottom line

As of May 8, 2026, GEHC has a composite score of 17.4 and a signal label of "mild favorable." The score is influenced by a medium confidence level of 72.1, with strengths in management (65.9) and quality (65.5), but a notable weakness in momentum (-30.2). The analysis is provisional and reflects various macroeconomic factors, including labor and sector trends.

Composite +17as of 2026-05-08

Price

Daily closes from AlphaVantage. Earnings/event dots are placed inline.

Close 2026-05-08
Daily closes. Scroll over the chart to zoom; click a range to reset.
EarningsMaterial event

Factor signals

Read top-to-bottom: thesis (is this a strong company over a 1–3 year hold), watch flags (has something changed worth re-reading), and position context (how violent might the path be). Each pill is a parallel diagnostic — never aggregated into a single score.

L1

Thesis

is this a strong company over a 1–3 year hold?
F1 · Recent financial performance
strong
Top 20% of health care cohort
Why this rank
  • Direction share
    1.00
  • Slope (norm)
    0.11
  • Bonus
    0.00
Operating income, last 4 quarters ($M)
540654653778
F2 · Value
cheap
Cheapest 20% of health care cohort
Why this rank
Price
$63.47
TTM EPS
$3.87
Earnings yield
6.1%
P/E (TTM)
16.4

Trailing four: 2024-Q3, 2025-Q1, 2025-Q2, 2025-Q3

F3 · Earnings quality
fragile
Bottom 20% cash conversion in health care cohort
Why this rank
TTM NI ($M)
1,993
TTM CFO ($M)
1,955
CFO/NI
0.98
L2

Watch

has something changed worth re-reading?
F4 · Management stability
neutral
Mid-cohort activity· see deep-dive ↓
capital unfriendlyBottom 20% — net capital-unfriendly direction
Earnings setup · pre-print positioning
forward-looking
bearishEPS revised -10.9% / 30d, n=15for period ending 2026-06-30
Why this setup
Consensus revisions

EPS estimate $1.16 → $1.04 (-10.9% / 30d). 1 raised, 14 cut, 15 covering analysts.

Rating actions

0 upgrades, 1 downgrade / 30d, 10 maintained. 65% of analysts rate Buy.

Price target activity

7 PT revisions / 30d. Avg target 27.6% above current price.

Material events

0 positive, 0 negative / 30d.

F4 · Management deep-dive — recent events, stated priorities, guidance track record
2

Stated priorities

3 priorityies extracted from earnings transcripts (as of 2026-05-08).

  1. 1.Maintain strong cash flow from operationscapital allocationmixed30% progressprovisional
    2/4: CFO: 'We continue to prioritize strong cash flow from operations to fund our strategic initiatives.'
    Why this status

    Stated in 3 of last 3 quarters. Cash from operations was $255M in 2025-Q4, down from $937M in 2025-Q3, indicating a decline. Despite management's focus, the trajectory shows limited progress in maintaining strong cash flow.

  2. 2.Enhance operating incomecostmixed65% progressprovisional
    2/4: CEO: 'We are committed to enhancing our operating income through strategic measures.'
    Why this status

    Stated in 3 of last 3 quarters. Operating income was $778M in 2025-Q4, up from $653M in 2025-Q3, showing improvement. Management's focus on enhancing operating income is delivering positive results.

  3. 3.Increase revenue growthgrowthbehind0% progressprovisional
    2/4: CEO: 'We aim to drive revenue growth through strategic initiatives.'
    Why this status

    Stated in 3 of last 3 quarters. Revenue was $4.872B in 2025-Q4, down from $5.143B in 2025-Q3, indicating a decline. Despite management's emphasis on growth, the trajectory shows limited progress in increasing revenue.

3

Guidance track record

Insufficient guidance history for this ticker.

L3

Position context

how violent might the path be while I hold it?
Risk profile · realized
backward-looking
moderateworst 12m loss −32%, typical day ±1.2%
Why this risk level

Recent vol — 30d annualized 52%; 252d 33%.

Drawdown — Max 1y −32%. Bad day move −3%.

Beta to sector ETF (XLV) 0.98 over 1y.

Liquidity — score 100/100.

Sub-scores — vol 45/100, drawdown 35/100, beta 98/100, earnings vol .

Sector regime
headwind-15.1%sector vs S&P 500, 60d

via XLV

Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive — historically, headwind regimes have averaged stronger forward returns than tailwind.

AI cycle regime · market-wide
2-axis classifier
HeatingManiaSquallCrisisEarnings →Mood ↑
HeatingE +0.13 · M +0.71
Single-axisCHASEz +2.97+1.285d

Context label only — describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.

Not investment advice. As of 2026-05-08.

3

What changed

The most important moves since the prior daily snapshot.

  1. No material changes since the prior snapshot.

No material changes since the prior snapshot.

as of 2026-05-08

4

Management scorecard

How management runs the business — capital, margins, balance sheet, and how reliably they guide and deliver.

Composite65.9 / 100
Capital allocation66
Earnings discipline58
Margin discipline72
Balance sheet83
Guidance credibility
Post-call reaction42
as of 2026-05-08
4

What management is focused on

Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.

  • #1

    Maintain strong cash flow from operations

    Capital allocation

    Focus on sustaining robust cash flow from operations to support business activities.

    Mixed

    Stated in 3 of last 3 quarters. Cash from operations was $255M in 2025-Q4, down from $937M in 2025-Q3, indicating a decline. Despite management's focus, the trajectory shows limited progress in maintaining strong cash flow.

    30%
    CEO/CFO:CFO: 'We continue to prioritize strong cash flow from operations to fund our strategic initiatives.'
    Earnings callSource dated 2026-02-04Stated 3 of last 8 quartersFirst seen 2026-02-04provisional
    Show history (3)
    • 2025-Q4Earnings call

      CFO: 'We continue to prioritize strong cash flow from operations...'

    • 2025-Q3Earnings call

      CFO: 'Our cash flow from operations remains a key focus area.'

    • 2025-Q2Earnings call

      CFO: 'Sustaining cash flow from operations is critical for our growth.'

  • #2

    Enhance operating income

    Cost

    Aim to improve operating income through efficiency and strategic initiatives.

    Mixed

    Stated in 3 of last 3 quarters. Operating income was $778M in 2025-Q4, up from $653M in 2025-Q3, showing improvement. Management's focus on enhancing operating income is delivering positive results.

    65%
    CEO/CFO:CEO: 'We are committed to enhancing our operating income through strategic measures.'
    Earnings callSource dated 2026-02-04Stated 3 of last 8 quartersFirst seen 2026-02-04provisional
    Show history (3)
    • 2025-Q4Earnings call

      CEO: 'We are committed to enhancing our operating income...'

    • 2025-Q3Earnings call

      CEO: 'Improving operating income remains a priority.'

    • 2025-Q2Earnings call

      CEO: 'Focus on boosting operating income through efficiency.'

  • #3

    Increase revenue growth

    Growth

    Drive revenue growth through strategic initiatives and market expansion.

    Behind

    Stated in 3 of last 3 quarters. Revenue was $4.872B in 2025-Q4, down from $5.143B in 2025-Q3, indicating a decline. Despite management's emphasis on growth, the trajectory shows limited progress in increasing revenue.

    0%
    CEO/CFO:CEO: 'We aim to drive revenue growth through strategic initiatives.'
    Earnings callSource dated 2026-02-04Stated 3 of last 8 quartersFirst seen 2026-02-04provisional
    Show history (3)
    • 2025-Q4Earnings call

      CEO: 'We aim to drive revenue growth through strategic initiatives.'

    • 2025-Q3Earnings call

      CEO: 'Revenue growth is a key focus for us.'

    • 2025-Q2Earnings call

      CEO: 'Our strategy is centered on revenue growth.'

as of 2026-05-08
5

How this stock is priced

Two ways to read price: against peers in the same business, and against the company's own history.

Compared to peers
75higher = cheaper

Looks cheaper than most peers in the same business.

Compared to its own history
97higher = cheaper

Cheaper than its own typical valuation.

P/E
13.9x
EV/EBITDA
FCF yield
5.4%

P/E over the last 5 years

38 monthly points
inexpensiveas of 2026-05-08
7

How this compares

A side-by-side read on composite, valuation, and risk versus peers.

StockCompositeValuationRisk
GEHC
GE HealthCare
+17inexpensivemoderate
LLY
Lilly (Eli)
+21fullmoderate
JNJ
Johnson & Johnson
+18fulllow
ABBV
AbbVie
+12fairlow
UNH
UnitedHealth Group
+24fairelevated
8

Risk — how this stock moves

What a normal day looks like, what a bad day looks like, and the worst the last year has thrown at it.

A typical day
How much price usually moves either way.
1.2%
A bad day (95th %ile)
A rough but not unusual down day.
-3.3%
Worst 12-month loss
Deepest peak-to-trough drop in the last year.
-32.5%
Earnings-day move
How much price usually moves on earnings day.
moderateas of 2026-05-08
9

What could change this view

Conditional scenarios — if X happens, the score would shift by about Y points. These are not predictions.

Upside triggers
  • If health_care sector trend rises from +0.06 into 'improving' (>= +0.20)+5.0 pts
  • If next-quarter guidance is raised (currently NEW as of 2023-01-10)+4.0 pts
Downside triggers
  • If next-quarter guidance is cut (currently NEW as of 2023-01-10)-8.0 pts
  • If labor state reverses from -0.31 (negative) to +0.31 (positive)-6.8 pts
  • If health_care sector trend falls from +0.06 into 'weakening' (<= -0.20)-5.0 pts
10

Material updates

Recent SEC 8-K filings ranked by likely impact, confidence, and recency.

  1. 2026-04-299d agoItem 2.02

    Results of Operations and Financial Condition. On April 29, 2026 , GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its first quarter 2026 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K. The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise…

    earnings preannouncementneutralscore 53
  2. 2026-03-171mo agoItem 5.02

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 13, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (the “Company”) appointed Kevin A. Lobo to serve as a director of the Company, effective immediately. Mr. Lobo’s term will expire at the Company’s 2026 Annual Meeting of Stockholders. The Board also appointed Mr. Lobo as a member of the Talent, Culture, and C…

    executive changeneutralscore 17
  3. 2026-02-272mo agoItem 1.01

    Entry into a Material Definitive Agreement. On February 26, 2026, GE HealthCare Technologies Inc. (the “Company”) entered into a 364-Day Revolving Credit Agreement (the “New Revolving Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides for a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $0.5 billion. The New Revolving Credit Facility replaces the 364-Day Revolving Credi…

    capital allocationneutralscore 13
  4. 2026-02-272mo agoItem 1.02

    Termination of a Material Definitive Agreement. In connection with the Company’s entry into the New Revolving Credit Agreement, the 2025 364-Day Revolving Credit Agreement, which provided for a $0.5 billion 364-day senior unsecured revolving credit facility, was terminated without penalty on February 26, 2026.

    mna activitynegativescore 10
  5. 2026-02-272mo agoItem 2.03

    Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information provided in

    capital allocationnegativescore 10
11

Score history

The composite score, snapshot by snapshot. The dotted line at zero separates leaning-positive from leaning-negative.

60 snapshots
Data freshness · As of 2026-05-08 · Macro 2026-05-08 · Sector 2026-05-07 · Fundamentals 2026-02-04 · Price 2026-05-07 · Generated 2026-05-08 · Spec 2.3

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.